BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Souza RF, Spechler SJ. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:105-15. [PMID: 33213790 DOI: 10.1016/j.giec.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Webster JA, Wuethrich A, Shanmugasundaram KB, Richards RS, Zelek WM, Shah AK, Gordon LG, Kendall BJ, Hartel G, Morgan BP, Trau M, Hill MM. Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma. Cancers (Basel) 2021;13:2865. [PMID: 34201241 DOI: 10.3390/cancers13122865] [Reference Citation Analysis]
2 Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, Rangel Latuche L, Schulte PJ. Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00190-2. [PMID: 35217151 DOI: 10.1016/j.cgh.2022.02.033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bajpai M, Panda A, Birudaraju K, Van Gurp J, Chak A, Das KM, Javidian P, Aviv H. Recurring Translocations in Barrett's Esophageal Adenocarcinoma. Front Genet 2021;12:674741. [PMID: 34178034 DOI: 10.3389/fgene.2021.674741] [Reference Citation Analysis]